Misexpression of DNM1L and Mfn1/2 may underlie several human hematological malignancies including acute myeloid leukemia (AML), chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL) and myelodysplastic syndromes1,2. This evidence concerns the gene MFN1 and hematologic disorder.